Synthetic Circuit-Driven Expression of Heterologous Enzymes for Disease Detection
The integration of nanotechnology and synthetic biology could lay the framework for new classes of engineered biosensors that produce amplified readouts of disease states. As a proof-of-concept demonstration of this vision, here we present an engineered gene circuit that, in response to cancer-assoc...
Main Authors: | He, Jiang, Nissim, Lior, Soleimany, Ava P, Binder-Nissim, Adina, Fleming, Heather E, Lu, Timothy K, Bhatia, Sangeeta N |
---|---|
Other Authors: | Koch Institute for Integrative Cancer Research at MIT |
Format: | Article |
Language: | English |
Published: |
American Chemical Society (ACS)
2022
|
Online Access: | https://hdl.handle.net/1721.1/142861 |
Similar Items
-
Synthetic RNA-Based Immunomodulatory Gene Circuits for Cancer Immunotherapy
by: Stupp, Doron, et al.
Published: (2018) -
Cellular heterogeneity mediates inherent sensitivity–specificity tradeoff in cancer targeting by synthetic circuits
by: Morel, Mathieu, et al.
Published: (2018) -
Synthetic and living micropropellers for convection-enhanced nanoparticle transport
by: Schuerle, S, et al.
Published: (2020) -
Multiplexed and Programmable Regulation of Gene Networks with an Integrated RNA and CRISPR/Cas Toolkit in Human Cells
by: Nissim, Lior, et al.
Published: (2016) -
Uncovering and Mitigating Algorithmic Bias through Learned Latent Structure
by: Soleimany, Ava, et al.
Published: (2019)